Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Value-Based Contracting Needs Federal Safe Harbors To Flourish, Lilly Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Lilly USA Deputy General Counsel Weems and former Anthem Chief Medical Officer Nussbaum offer insights on how guidance from the HHS Inspector General might help advance value-based contracting.

Advertisement

Related Content

HHS Action On Drug Pricing: Here's Who Secretary Price Is Listening To
Where Will It End? Lilly’s US Price Concessions Increase 30% In 2016
US Outcomes-Based Contracts: Big Uptick In Interest, But Not Execution
Medicare Part D Payment Demonstration Under Consideration At CMS
Medicare Risk-Sharing Contracts: A More Feasible Drug Cost Solution?
IG Compliance Guide Approach To CME, Consulting Concerns PhRMA

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS079512

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel